Reference range for the antimüllerian hormone Generation II assay: A population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram

Fertility and Sterility

Volumn 101, Issue 2, 2014, Pages

  Nelson, Scott M ^a   Iliodromiti, Stamatina ^a   Fleming, Richard ^a   Anderson, Richard ^b   McConnachie, Alex ^a   Messow, Claudia Martina ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Clinical pregnancy; GnRH agonist; GnRH antagonist; luteal support; ovarian hyperstimulation syndrome

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; AMH GENERATION II ASSAY; ARTICLE; CALIBRATION; CLINICAL LABORATORY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DSL ASSAY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MIDDLE AGED; MULTICENTER STUDY; NOMOGRAM; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

CLINICAL PREGNANCY; GNRH AGONIST; GNRH ANTAGONIST; LUTEAL SUPPORT; OVARIAN HYPERSTIMULATION SYNDROME;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NOMOGRAMS; POPULATION SURVEILLANCE; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 84895069571     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.10.021     Document Type: Article

References (36)

1. T.W. Kelsey, P. Wright, S.M. Nelson, R.A. Anderson, and W.H.B. Wallace A validated model of serum anti-müllerian hormone from conception to menopause PLoS One 2011 6
2. S. Iliodromiti, and S.M. Nelson Biomarkers of ovarian reserve Biomark Med 7 2013 147 158
3. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Humanit Rep Update 12 2006 685 718
4. T. Freour, S. Mirallie, K. Bach-Ngohou, M. Denis, P. Barriere, and D. Masson Measurement of serum Anti-müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART) Clin Chim Acta 375 2007 162 164
5. J. Taieb, C. Belville, C. Coussieu, J. Guibourdenche, J.Y. Picard, and N. Di Clemente Two immunoassays for antimüllerian hormone measurement: analytical and clinical performances Ann Biol Clin (Paris) 66 2008 537 547
6. S.M. Nelson, and A. La Marca The journey from the old to the new AMH assay: how to avoid getting lost in the values Reprod Biomed Online 23 2011 411 420
7. A. Kumar, B. Kalra, A. Patel, L. McDavid, and W.E. Roudebush Development of a second generation anti-müllerian hormone (AMH) ELISA J Immunol Methods 362 2010 51 59
8. A.M. Wallace, S.A. Faye, R. Fleming, and S.M. Nelson A multicentre evaluation of the new Beckman Coulter anti-müllerian hormone immunoassay (AMH Gen II) Ann Clin Biochem 48 2011 370 373
9. O. Rustamov, A. Smith, S.A. Roberts, A.P. Yates, C. Fitzgerald, and M. Krishnan et al. Anti-müllerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability Hum Reprod 27 2012 3085 3091
10. S.M. Nelson, M.C. Messow, A.M. Wallace, R. Fleming, and A. McConnachie Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients Fertil Steril 95 2011 736 741.e1-3
11. S.M. Nelson, M.C. Messow, A. McConnachie, H. Wallace, T. Kelsey, and R. Fleming et al. External validation of nomogram for the decline in serum anti-müllerian hormone in women: a population study of 15,834 infertility patients Reprod Biomed Online 23 2011 204 206
12. J.Y. Lee, B.C. Jee, J.R. Lee, C.H. Kim, T. Park, and B.R. Yeon et al. Age-related distributions of anti-müllerian hormone level and anti-müllerian hormone models Acta Obstet Gynecol Scand 91 2012 970 975
13. Team RDC. R Foundation for Statistical Computing, 2009, http://www.r-project.org/. Last accessed January 10, 2014.
14. Tornoe CW. nlmeODE: Non-linear mixed-effects modelling in nlme using differential equations. 2007, http://crantastic.org/packages/nlmeODE. Last accessed January 10, 2014.
15. Setzer RW. Odesolve: Solvers for ordinary differential equations. R package version 0.5-20, 2008, http://crantastic.org/packages/odesolve. Last accessed January 10, 2014.
16. Pinheiro J, Bates D, DebrRoy S, Sarkar D, Team RC. nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-92, 2009, http://www.inside-r.org/packages/cran/nlme. Last accessed January 10, 2014.
17. Beckman Coulter, Inc AMH Gen II ELISA 2013 Beckman Coulter Brea, CA
18. H.W. Li, E.H. Ng, B.P. Wong, R.A. Anderson, P.C. Ho, and W.S. Yeung Correlation between three assay systems for anti-müllerian hormone (AMH) determination J Assist Reprod Genet 29 2012 1443 1446
19. S.L. Broer, J. van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, and P. Bossuyt et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach Hum Reprod Update 19 2013 26 36
20. S.L. Broer, M. Dolleman, J. van Disseldorp, K.A. Broeze, B.C. Opmeer, and P.M. Bossuyt et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis Fertil Steril 100 2013 420 429 e7
21. S.L. Broer, M. Dolleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J.M. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
22. J.C. Arce, A. La Marca, B. Mirner Klein, A. Nyboe Andersen, and R. Fleming Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients Fertil Steril 99 2013 1644 1653 e1
23. E. Anckaert, J. Smitz, J. Schiettecatte, B.M. Klein, and J.C. Arce The value of anti-müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments Hum Reprod 27 2012 1829 1839
24. A.N. Andersen, H. Witjes, K. Gordon, and B. Mannaerts Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment Hum Reprod 26 2011 3413 3423
25. R. Riggs, T. Kimble, S. Oehninger, S. Bocca, Y. Zhao, and B. Leader et al. Anti-müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation Fertil Steril 95 2011 410 412
26. L.G. Nardo, T.A. Gelbaya, H. Wilkinson, S.A. Roberts, A. Yates, and P. Pemberton et al. Circulating basal anti-müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization Fertil Steril 92 2009 1586 1593
27. T.H. Lee, C.H. Liu, C.C. Huang, Y.L. Wu, Y.T. Shih, and N.N. Ho et al. Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Obstet Gynecol Surv 63 2008 378 379
28. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy Hum Reprod 22 2007 2414 2421
29. S.L. Broer, B.W.J. Mol, D. Hendriks, and F.J.M. Broekmans The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
30. J.E. Lee, J.R. Lee, B.C. Jee, C.S. Suh, K.C. Kim, and W.D. Lee et al. Clinical application of anti-müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome Clin Exp Reprod Med 39 2012 176 181
31. R. Satwik, M. Kochhar, S.M. Gupta, and A. Majumdar Anti-müllerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization J Hum Reprod Sci 5 2012 206 212
32. B. Friden, P. Sjoblom, and J. Menezes Using anti-müllerian hormone to identify a good prognosis group in women of advanced reproductive age Aust NZ J Obstet Gynaecol 51 2011 411 415
33. A. Weghofer, W. Dietrich, D.H. Barad, and N. Gleicher Live birth chances in women with extremely low-serum anti-müllerian hormone levels Hum Reprod 26 2011 1905 1909
34. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, and M. Gaudoin et al. Anti-müllerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
35. A.P. Yates, S.A. Roberts, and L.G. Nardo Anti-müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 27 2012 629
36. National Institute for Health and Care Excellence Fertility: assessment and treatment for people with fertility problems 2013 National Institute for Health and Care Excellence London